Ilkka Julkunen
ilkka.julkunen@utu.fi +358 29 450 4507 +358 50 449 9721 Kiinamyllynkatu 10 Turku |
Publications
- COVID-19 vaccine type controls stromal reprogramming in draining lymph nodes (2025)
- Science Immunology
(A1 Refereed original research article in a scientific journal) - HCoV-229E does not trigger early interferon gene expression and evades IFN signaling in human A549 lung epithelial cells (2025)
- Microbiology spectrum
(A1 Refereed original research article in a scientific journal) - Highly Pathogenic Avian Influenza (HPAI) H5N1 virus in Finland in 2021–2023 – Genetic diversity of the viruses and infection kinetics in human dendritic cells (2025)
- Emerging microbes & infections
(A1 Refereed original research article in a scientific journal) - Influenza A(H5N8) vaccine induces humoral and cell-mediated immunity against highly pathogenic avian influenza clade 2.3.4.4b A(H5N1) viruses in at-risk individuals (2025)
- Nature Microbiology
(A1 Refereed original research article in a scientific journal) - Long-term neutralization capacity of vaccine and breakthrough infection induced SARS-CoV-2 specific antibodies against omicron subvariants BA.2, XBB.1.5, and JN.1 (2025)
- Vaccine
(A1 Refereed original research article in a scientific journal) - Post-COVID-19 condition in prospective inpatient and outpatient cohorts (2025)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosis (2025)
- Scandinavian Journal of Immunology
(A1 Refereed original research article in a scientific journal) - Evaluation of a Novel Point-of-Care Blood Myxovirus Resistance Protein A Measurement for the Detection of Viral Infection at the Pediatric Emergency Department (2024)
- Journal of Infectious Diseases
(A1 Refereed original research article in a scientific journal) - High Glucose Increases Lactate and Induces the Transforming Growth Factor Beta-Smad 1/5 Atherogenic Pathway in Primary Human Macrophages (2024)
- Biomedicines
(A1 Refereed original research article in a scientific journal) - Kasvutekijäreseptorit (2024) Patologia Julkunen, Ilkka
(D2 Article in a professional compilation book) - Kasvutekijät (2024) Patologia Julkunen, Ilkka
(D2 Article in a professional compilation book) - Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity (2024)
- Frontiers in immunology
(A1 Refereed original research article in a scientific journal) - Luontaiset puolustusmekanismit (2024) Mikrobiologia, immunologia ja infektiosairaudet. Kirja 2, Immunologia Meri, Seppo; Julkunen, Ilkka
(D2 Article in a professional compilation book) - Mikrobien aiheuttamat epidemiat ja pandemiat - mikrobiologian laboratorioiden varautuminen (2024)
- Infektioidentorjunta
(D1 Article in a professional journal) - Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection (2024)
- Communications medicine
(A1 Refereed original research article in a scientific journal) - Sytokiinien ja kasvutekijöiden toiminnan häiriöt ja kliininen käyttö (2024) Patologia Julkunen, Ilkka
(D2 Article in a professional compilation book) - Sytokiinireseptorit (2024) Patologia Julkunen, Ilkka
(D2 Article in a professional compilation book) - Sytokiinit (2024) Patologia Julkunen, Ilkka
(D2 Article in a professional compilation book) - The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base (2024)
- Cell Discovery
(A1 Refereed original research article in a scientific journal) - Virusinfektioiden immunologia (2024) Mikrobiologia, immunologia ja infektiosairaudet. Kirja 2, Immunologia Julkunen, Ilkka; Arstila, Petteri; Silvennoinen, Olli
(D2 Article in a professional compilation book)



